Teitl: To establish a scalable set of assay platforms against which the phenotype consequences of manipulating the identified exclusive targets can be screened and effects the drug compounds assessed to develop therapeutics for schizophrenia

Arianwyr
Takeda Pharmaceutical Company Ltd

Prif Ymchwiliwr

Manylion y Prosiect
Gwerth net y ffigur a ddyfarnwyd i Brifysgol Caerdydd: £2,960,749.00
Dyddiad dechrau: 01.10.2018
Dyddiad gorffen: 31.03.2023

Diweddarwyd y tro diwethaf ar 2020-05-04 am 06:01